Drugs / DPV-001 vaccine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02737475 Background | Jun 2016 → Nov 2020 | cancer of unknown primary site | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DPV-001 vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02737475 ↗ |
| Modality | Vaccine | “BMS-986178/Nivolumab/DPV-001 vaccine/cyclophosphamide” NCT02737475 ↗ |